Resmed CDI (ASX:RMD)
Health Care Equipment & Services
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Resmed CDI (ASX:RMD) share price
Resmed CDI (ASX:RMD) passive income
Resmed CDI (ASX:RMD) share price news
ASX Bank Shares
Traders stay on sideline ahead of October rates call
It was relatively quiet on the ASX on Monday with traders eyeing the Reserve Bank of Australia’s latest interest-rate decision, to be announced today (and a public holiday in most states dampening activity further).
October 3, 2023
ASX Growth Shares
All Ordinaries (ASX:XAO) holds on despite tech selloff: Inflation increases to 5.2%
The tech sector fell 1% and healthcare 0.7% as bond yields continue to increase around the world and place pressure on long-term growth companies.
September 28, 2023
ASX Bank Shares
The Match Out: Resilience remains as stocks close marginally lower
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.11% to 7030.30.
September 27, 2023
ASX Bank Shares
Pro Medicus (ASX:PME) shines amid tech sell off: All Ordinaries (ASX:XAO) falls
Pro Medicus Limited (ASX: PME) was a standout, adding 12.4%. The radiology imaging technology firm announced another $140 million ten year contract in the US as the business continues to scale quickly.
September 27, 2023
ASX Bank Shares
The Match Out: Shares slip, but Uranium shares rip!
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.45% to 7044.90.
September 26, 2023
ASX Growth Shares
Why We’re Bullish on Resmed – A Deeper Dive into GLP-1 Treatments
The Resmed CDI (ASX: RMD) share price is down over 30% over the past 12 months as analysts and investors weigh up the long-term impact of GLP-1 treatments on RMD’s obstructive sleep apnea (OSA) market.
September 20, 2023
ASX Growth Shares
Four Big Oversold Stocks with 6% Yields
Marcus Today does Technical Scans every day, and on 15 September 2023, they turned up four big stocks (five if you include Resmed CDI (ASX: RMD), seven including resources) that are interestingly oversold on weekly charts.
September 19, 2023
ASX Growth Shares
The Match Out: S&P/ASX 200 (INDEXASX:XJO) falls ahead of key US inflation data
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down +0.74% to 7153.90.
September 13, 2023
ASX Growth Shares
The Match Out: S&P/ASX 200 (INDEXASX:XJO) edges higher
Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished up +0.20% to 7206.90.
September 12, 2023